Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Jack Nathan Medical Corp V.JNH

Alternate Symbol(s):  JNHMF

Jack Nathan Medical Corp., operating as Jack Nathan Health, is a Canada-based healthcare network operator. Jack Nathan Health is a healthcare company that is improving access for millions of patients by co-locating physicians and ancillary medical services conveniently inside Walmart stores. Jack Nathan Health provides patient care, made possible through patient-centric physicians, a variety of medical services, technology, and programs, designed to put patients first. In Canada, the Company has 80 clinics in Walmart locations in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, and Quebec and two independent locations for a total of 82 clinics. There are over 22 corporate owned and operated clinics, of which three include Rehab services and six include MedSpa services. In Mexico, the Company has over 155 corporate owned and operated clinics in Walmart locations, five clinics inside Walmart Distribution Centers servicing Walmart Associates, and one Multidisciplinary clinic.


TSXV:JNH - Post by User

Comment by blackgold14on Mar 30, 2021 5:07pm
189 Views
Post# 32908210

RE:RE:RE:RE:RE:chart

RE:RE:RE:RE:RE:chart You've posted misinformation.  The listing expense of over $7.9 million (outrageous as I see it) will ensure that the company will report a massive loss for its year ended January 31, 2021. It's not a past issue as you labelled it.  As far as the float and the warrants - irrelevant - the fact is that the stock was $2.50 five months ago and is now in the low 70 cent range. If I had bought at that level, I would be royally pissed.  I didn't but the ones that did are probably selling now and further depressing the price.  Also, the holders of the dirt cheap stock at 50 cents have probably been liquidating.  As far as the reporting date for the first quarter, big deal, one less month to go - if I was a betting man, I would bet that the company will report a net loss for the quarter.  Profitability may be increasing, but they could and probably will stil report a loss. Acquisitions are normally accompanied by higher adminstrative/consulting/professional fees.   Revenue for the last reported quarter was under $1 million.  If it goes to $3 million for the Q4 ended January 2021, they still won't avoid reporting a massive loss for the year ended January 31, 2021.
<< Previous
Bullboard Posts
Next >>